Abstract

Abstract Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable but hypertension and proteinuria are usually seen. These systemic signs arise from soluble factors released from the placenta as a result of a response to stress of syncytiotrophoblast. There are two sub-types: early and late onset pre-eclampsia, with others almost certainly yet to be identified. Early onset pre-eclampsia arises owing to defective placentation, whilst late onset pre-eclampsia may center around interactions between normal senescence of the placenta and a maternal genetic predisposition to cardiovascular and metabolic disease. The causes, placental and maternal, vary among individuals. Recent research has focused on placental-uterine interactions in early pregnancy. The aim now is to translate these findings into new ways to predict, prevent, and treat pre-eclampsia.

Keywords

EclampsiaPlacentationSyncytiotrophoblastPlacentaPregnancyDiseaseMedicinePreeclampsiaPathophysiologyProteinuriaObstetricsBioinformaticsFetusBiologyEndocrinologyInternal medicineGenetics

Affiliated Institutions

Related Publications

Preeclampsia

Hypertensive disorders of pregnancy—chronic hypertension, gestational hypertension, and preeclampsia—are uniquely challenging as the pathology and its therapeutic management sim...

2019 Circulation Research 1807 citations

Publication Info

Year
2019
Type
review
Volume
366
Pages
l2381-l2381
Citations
1126
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1126
OpenAlex

Cite This

Graham J. Burton, Christopher W.G. Redman, James M. Roberts et al. (2019). Pre-eclampsia: pathophysiology and clinical implications. BMJ , 366 , l2381-l2381. https://doi.org/10.1136/bmj.l2381

Identifiers

DOI
10.1136/bmj.l2381